Massachusetts Financial Services Co. MA Buys 70,440 Shares of Masimo Co. (NASDAQ:MASI)

Massachusetts Financial Services Co. MA boosted its stake in Masimo Co. (NASDAQ:MASI - Free Report) by 9.8% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 792,166 shares of the medical equipment provider's stock after buying an additional 70,440 shares during the quarter. Massachusetts Financial Services Co. MA owned approximately 1.48% of Masimo worth $105,619,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the stock. Farallon Capital Management LLC raised its holdings in shares of Masimo by 13.6% during the first quarter. Farallon Capital Management LLC now owns 1,489,563 shares of the medical equipment provider's stock worth $218,742,000 after acquiring an additional 177,914 shares in the last quarter. Thrivent Financial for Lutherans lifted its stake in shares of Masimo by 42.1% in the second quarter. Thrivent Financial for Lutherans now owns 1,217,357 shares of the medical equipment provider's stock worth $153,314,000 after buying an additional 360,497 shares during the last quarter. Point72 Asset Management L.P. boosted its holdings in shares of Masimo by 107.8% during the 2nd quarter. Point72 Asset Management L.P. now owns 677,677 shares of the medical equipment provider's stock worth $85,347,000 after buying an additional 351,523 shares during the period. Dimensional Fund Advisors LP grew its stake in Masimo by 45.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 525,594 shares of the medical equipment provider's stock valued at $66,201,000 after buying an additional 165,257 shares during the last quarter. Finally, ING Groep NV raised its holdings in Masimo by 143.3% in the 3rd quarter. ING Groep NV now owns 240,900 shares of the medical equipment provider's stock worth $32,119,000 after acquiring an additional 141,900 shares during the period. Institutional investors and hedge funds own 85.96% of the company's stock.

Analyst Ratings Changes

MASI has been the subject of several research analyst reports. Wells Fargo & Company boosted their price objective on Masimo from $160.00 to $171.00 and gave the stock an "overweight" rating in a research report on Wednesday, November 6th. Stifel Nicolaus reiterated a "buy" rating and issued a $190.00 target price (up previously from $170.00) on shares of Masimo in a research note on Friday. BTIG Research upped their price target on Masimo from $166.00 to $170.00 and gave the company a "buy" rating in a report on Monday, October 14th. Raymond James raised Masimo from a "market perform" rating to an "outperform" rating and set a $170.00 price objective on the stock in a report on Wednesday, November 6th. Finally, Piper Sandler upped their target price on Masimo from $165.00 to $180.00 and gave the company an "overweight" rating in a research note on Wednesday, November 6th. Three research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $167.00.

Masimo Trading Up 2.3 %

Shares of Masimo stock traded up $3.84 during trading hours on Friday, hitting $172.96. The company's stock had a trading volume of 1,036,209 shares, compared to its average volume of 648,157. Masimo Co. has a 12 month low of $91.60 and a 12 month high of $174.34. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11. The company has a market capitalization of $9.26 billion, a PE ratio of 119.28 and a beta of 0.97. The stock has a 50 day moving average of $143.48 and a 200 day moving average of $127.94.

Masimo (NASDAQ:MASI - Get Free Report) last issued its quarterly earnings data on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.84 by $0.14. The company had revenue of $504.60 million during the quarter, compared to the consensus estimate of $502.87 million. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The firm's revenue was up 5.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.63 earnings per share. Analysts predict that Masimo Co. will post 4.04 earnings per share for the current year.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.